OptiNose, Inc. informed that Joseph Scodari will be retiring from the Company's Board of Directors (the "Board") following the Company's 2023 Annual Meeting of Stockholders in June 2023. Mr. Scodari currently serves as the Chairman of the Board, a member of the Compensation Committee of the Board and Chairman of the Nominating and Corporate Governance Committee of the Board. Effective upon Mr. Scodari's retirement, the size of the Board will be reduced from nine (9) members to eight (8) members and R. John Fletcher will serve as Chairman of the Board and fill the vacancies that will be created by Mr. Scodari's retirement as a member of the Compensation Committee and Chairman of the Nominating and Corporate Governance Committee.

Mr. Fletcher will also continue to serve as a member of the Audit Committee of the Board. Mr. Fletcher has been a member of the Board since April 2022 and the Board has determined that he is an "independent" director under the listing rules of The Nasdaq Stock Market LLC.